Stock TKD TAKEDA PHARMACEUTICAL COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Takeda Pharmaceutical Company Limited Wiener Boerse

Equities

TKD

JP3463000004

End-of-day quote Wiener Boerse
Other stock markets
 06:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
24.73 EUR +0.41% Intraday chart for Takeda Pharmaceutical Company Limited +1.35% -4.22%
Jul. 09 Takeda Issues New Shares, Disposes of Treasury Shares Under Incentive Scheme MT
Jul. 03 Blackstone selling Japan drugmaker Alinamin to MBK Partners RE

Analyst Reco.

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Toyota becomes Asia's most shorted large-cap stock - Hazeltree
RE
Jefferies Adjusts Takeda Pharmaceutical's Price Target to 5,600 Yen From 5,200 Yen, Keeps at Buy
MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,200 Yen From 5,300 Yen, Keeps at Buy
MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,300 Yen From 5,100 Yen, Keeps at Buy
MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,100 Yen From 5,000 Yen, Keeps at Buy
MT
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $20 From $30, Maintains Outperform Rating
MT
TD Cowen Adjusts Price Target on Takeda Pharmaceutical to $30 From $24, Keeps Outperform Rating
MT
BofA Securities Upgrades Takeda Pharmaceutical to Buy From Neutral, Price Target $20
MT
Jefferies Adjusts Takeda Pharmaceutical’s Price Target to 5,000 Yen From 4,600 Yen, Keeps at Buy
MT
Jefferies Downgrades Takeda Pharmaceutical to Hold From Buy
MT
Cowen Upgrades Takeda Pharmaceutical to Outperform From Market Perform
MT
TAKEDA PHARMACEUTICAL : Morgan Stanley Downgrades Takeda Pharmaceutical to Equal-weight From Overweight
MT
Japanese shares fall on profit booking, checking U.S. rates
RE
Takeda Pharmaceutical : Says Phase 3 Study Results Show Takhzyro Curbed HAE Attack Rate Long Term
MT
Takeda Pharmaceutical Company Limited: Takeda Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year
EQ
Takeda Pharmaceutical : Reports Strong First Quarter FY2019 Results and Raises Guidance for the Full Year
BU
Takeda Pharmaceutical : Announces Execution of Loan Agreement in Connection with Proposed Acquisition of Shire plc
BU
Takeda Pharmaceutical : Announces Execution of Senior Short Term Loan Facility Agreement and Subordinated Syndicated Loan Agreement and Second Amendment to Bridge Credit Agreement in Connection with Proposed Acquisition of Shire plc
BU
BAYER : Germany's Merck hires JP Morgan to sell consumer health
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4502 Stock
  4. TKD Stock
  5. News Takeda Pharmaceutical Company Limited
  6. Analyst Reco.